Qube Research & Technologies (QRT)’s Aura Biosciences AURA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$778K	Buy	+109,564	New	+$784K	﹤0.01%	2508

Other funds holding AURA

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AURA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Aura Biosciences (AURA) in Q2 2026: 109,564 shares worth $778K. The stake represents ﹤0.01% of the portfolio and ranks #2508 among its holdings.

147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

Qube Research & Technologies (QRT) held 109,564 shares of Aura Biosciences worth $778K as of Q2 2026.
Aura Biosciences was a new Qube Research & Technologies (QRT) position in Q2 2026.
Aura Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2508 holding.
147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.